The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
Current treatments for patients with relapsed or refractory chronic lymphocytic leukemia have shown better outcomes than ...
In patients with low-grade prostate cancer, adhering to the recommended dietary guidelines may slow the risk of prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback